Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Barakos

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Anatomical Record (Hoboken, N.J. : 2007)|September 22, 2009
Neuroanatomy and volumes of brain structures of a live California sea lion (Zalophus californianus) from magnetic resonance imagesEric W Montie, Nicola Pussini, Gerald E Schneider, et al.
Diseases of Aquatic Organisms|December 8, 2010
Magnetic resonance imaging quality and volumes of brain structures from live and postmortem imaging of California sea lions with clinical signs of domoic acid toxicosisEric W Montie, Elizabeth Wheeler, Nicola Pussini, et al.
Alzheimer Disease and Associated Disorders|February 18, 2016
Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical TrialJeff Sevigny, Joyce Suhy, Ping Chiao, et al.
Epilepsia|December 17, 2009
Involvement of the thalamocortical network in TLE with and without mesiotemporal sclerosisSusanne G Mueller, Kenneth D Laxer, Jerome Barakos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 23, 2023
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's diseaseLawrence S Honig, Jerome Barakos, Shobha Dhadda, et al.
Journal of Neurology|October 27, 2010
Widespread extrahippocampal NAA/(Cr+Cho) abnormalities in TLE with and without mesial temporal sclerosisSusanne G Mueller, Andreas Ebel, Jerome Barakos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2015
Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysisH Michael Arrighi, Jerome Barakos, Frederik Barkhof, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 29, 2023
Validation of 3- and 5-point severity scales to assess ARIA-ELuc Bracoud, Gregory Klein, Marco Lyons, et al.
BMC Neurology|November 24, 2021
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trialR Matthew Hutchison, Karleyton C Evans, Tara Fox, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 7, 2022
Comparing ARIA-E severity scales and effects of treatment management thresholdsGregory Klein, Marzia A Scelsi, Jerome Barakos, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Anatomical Record (Hoboken, N.J. : 2007)|September 22, 2009
Neuroanatomy and volumes of brain structures of a live California sea lion (Zalophus californianus) from magnetic resonance imagesEric W Montie, Nicola Pussini, Gerald E Schneider, et al.
Diseases of Aquatic Organisms|December 8, 2010
Magnetic resonance imaging quality and volumes of brain structures from live and postmortem imaging of California sea lions with clinical signs of domoic acid toxicosisEric W Montie, Elizabeth Wheeler, Nicola Pussini, et al.
Alzheimer Disease and Associated Disorders|February 18, 2016
Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical TrialJeff Sevigny, Joyce Suhy, Ping Chiao, et al.
Epilepsia|December 17, 2009
Involvement of the thalamocortical network in TLE with and without mesiotemporal sclerosisSusanne G Mueller, Kenneth D Laxer, Jerome Barakos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 23, 2023
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's diseaseLawrence S Honig, Jerome Barakos, Shobha Dhadda, et al.
Journal of Neurology|October 27, 2010
Widespread extrahippocampal NAA/(Cr+Cho) abnormalities in TLE with and without mesial temporal sclerosisSusanne G Mueller, Andreas Ebel, Jerome Barakos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2015
Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysisH Michael Arrighi, Jerome Barakos, Frederik Barkhof, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 29, 2023
Validation of 3- and 5-point severity scales to assess ARIA-ELuc Bracoud, Gregory Klein, Marco Lyons, et al.
BMC Neurology|November 24, 2021
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trialR Matthew Hutchison, Karleyton C Evans, Tara Fox, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 7, 2022
Comparing ARIA-E severity scales and effects of treatment management thresholdsGregory Klein, Marzia A Scelsi, Jerome Barakos, et al.
Pageof 3